- Home
- ARQQ vs CVRX Comparison
ARQQ vs CVRX Comparison
Compare ARQQ & CVRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ARQQ
- CVRX
- Stock Information
- Founded
- ARQQ 2017
- CVRX 2000
- Country
- ARQQ United Kingdom
- CVRX United States
- Employees
- ARQQ N/A
- CVRX N/A
- Industry
- ARQQ Computer Software: Prepackaged Software
- CVRX Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- ARQQ Technology
- CVRX Health Care
- Exchange
- ARQQ Nasdaq
- CVRX Nasdaq
- Market Cap
- ARQQ 282.1M
- CVRX 311.3M
- IPO Year
- ARQQ N/A
- CVRX 2021
- Fundamental
- Price
- ARQQ $29.29
- CVRX $12.11
- Analyst Decision
- ARQQ Strong Buy
- CVRX Buy
- Analyst Count
- ARQQ 1
- CVRX 7
- Target Price
- ARQQ $27.00
- CVRX $16.67
- AVG Volume (30 Days)
- ARQQ 1.4M
- CVRX 187.2K
- Earning Date
- ARQQ 12-31-2024
- CVRX 01-23-2025
- Dividend Yield
- ARQQ N/A
- CVRX N/A
- EPS Growth
- ARQQ N/A
- CVRX N/A
- EPS
- ARQQ N/A
- CVRX N/A
- Revenue
- ARQQ $293,000.00
- CVRX $47,255,000.00
- Revenue This Year
- ARQQ $3,516.04
- CVRX $31.78
- Revenue Next Year
- ARQQ N/A
- CVRX $26.42
- P/E Ratio
- ARQQ N/A
- CVRX N/A
- Revenue Growth
- ARQQ N/A
- CVRX 34.38
- 52 Week Low
- ARQQ $3.72
- CVRX $6.40
- 52 Week High
- ARQQ $42.90
- CVRX $33.14
- Technical
- Relative Strength Index (RSI)
- ARQQ 56.31
- CVRX 38.54
- Support Level
- ARQQ $22.30
- CVRX $12.57
- Resistance Level
- ARQQ $42.90
- CVRX $13.68
- Average True Range (ATR)
- ARQQ 6.82
- CVRX 0.85
- MACD
- ARQQ 0.02
- CVRX -0.35
- Stochastic Oscillator
- ARQQ 31.69
- CVRX 17.11
About ARQQ Arqit Quantum Inc.
Arqit Quantum Inc is a cybersecurity company that has pioneered a symmetric key agreement technology that makes the communications links of any networked device or data at rest secure against current and future forms of cyber attack - even an attack from a quantum computer. The company delivers its symmetric key agreement technology via its product QuantumCloud. The firm operates in one segment that is, the provision of cybersecurity services via satellite and terrestrial platforms. The company operates and generates its revenue from UK.
About CVRX CVRx Inc.
CVRx Inc is a commercial-stage medical device company focused on developing, manufacturing, and commercializing minimally invasive neuromodulation solutions for patients with cardiovascular diseases. Its proprietary platform technology, Barostim, is designed to leverage the power of the brain to address the imbalance of the Autonomic Nervous System, which causes heart failure and other cardiovascular diseases. Barostim provides Baroreflex Activation Therapy which in turn triggers an autonomic response to the heart. The majority of revenue is derived from the USA market.